NCT02069470 The Effect of CME on Early Cancer Diagnosis in General Practice Status COMPLETED Phase NA
NCT02069080 Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor Status TERMINATED Phase EARLY_PHASE1
NCT02065063 A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT02063958 Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors Status COMPLETED Phase PHASE1
NCT02060578 Determinants of End-of-life Place of Care for Children Suffering From Cancer. Status COMPLETED Phase NA
NCT02057289 A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis Status TERMINATED Phase PHASE1
NCT02055066 A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer. Status COMPLETED Phase PHASE1
NCT02054754 Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02048865 Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients Status COMPLETED Phase PHASE2
NCT02044861 Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies Status UNKNOWN Phase PHASE1
NCT02041416 Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02040480 Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib Status COMPLETED Phase PHASE1
NCT02036008 Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial Status UNKNOWN Phase NA
NCT02035098 Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial Status COMPLETED Phase PHASE2/PHASE3
NCT02034929 EndoCuff-assisted Versus Standard Colonoscopy for Adenoma Detection Status COMPLETED Phase NA
NCT02034110 Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers Status COMPLETED Phase PHASE2
NCT02034097 A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02030379 Developing an Online Clinical Trial Specific Question Prompt List Status TERMINATED Phase NA